Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.21 - $0.39 $65,385 - $121,430
-311,361 Reduced 8.8%
3,227,696 $677,000
Q1 2023

May 15, 2023

BUY
$0.22 - $0.62 $2,699 - $7,607
12,270 Added 0.35%
3,539,057 $990,000
Q4 2022

Feb 10, 2023

BUY
$0.38 - $1.91 $115,963 - $582,867
305,166 Added 9.47%
3,526,787 $1.48 Million
Q3 2022

Nov 14, 2022

BUY
$1.46 - $2.38 $302,474 - $493,074
207,174 Added 6.87%
3,221,621 $5.19 Million
Q2 2022

Aug 12, 2022

BUY
$1.98 - $5.66 $4.52 Million - $12.9 Million
2,280,803 Added 310.89%
3,014,447 $6.06 Million
Q1 2022

May 13, 2022

SELL
$4.52 - $12.9 $2,449 - $6,991
-542 Reduced 0.07%
733,644 $3.93 Million
Q4 2021

Feb 14, 2022

BUY
$9.01 - $14.1 $6.62 Million - $10.4 Million
734,186 New
734,186 $9.16 Million

Others Institutions Holding SNCE

About Science 37 Holdings, Inc.


  • Ticker SNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 116,348,000
  • Description
  • Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evid...
More about SNCE
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.